PM360

AUGUST 9, 2022

Accordingly, multiple reasons for subpar patient adherence are gaining attention, including fear of side effects, lack of medical understanding, or even financial limitations. Measuring and monitoring adherence in clinical trials would add valuable information about the effectiveness and safety of drugs.

Medical 105

Medical Electronics Patients Healthcare 105

PM360

SEPTEMBER 15, 2022

Life sciences are being driven to improve the patient experience and are increasingly accomplishing this through innovative programs and resources for patients and physicians that improve access to medications, help make prescriptions more affordable, and support patients with adherence.

Patients 98

Patients Education Management Side effects 98

European Pharmaceutical Review

JANUARY 25, 2024

Within the EU, patient information leaflets (PILs) are not merely a regulatory requirement but a cornerstone of patient safety. They detail the medication’s intended use, proper administration, potential side effects and precautions. percent as EU average with some Member States as high as 25 percent).

Healthcare 84

Healthcare Healthcare Electronics Safety 84

PM360

AUGUST 9, 2022

The combined solution enables health plans and self-insured employers to realize immediate pharmacy cost savings and near-term medical cost reductions by integrating Levrx’s plan-specific and real-time prescription insights into the Adhere Platform medication optimization offerings. The Andaman7 Platform Solution. Vincent Keunen.

Prescription 105

Prescription Medical Side effects Patients 105

PM360

JULY 13, 2023

Nearly three in five people have experienced out-of-pocket prescription costs they couldn’t afford. In fact, after learning about prescription medications on Healthline Media’s website, 69% of visitors say they are extremely or very likely to refill their current prescription. Feb-May 2022. 1 References: 1.

Education 89

Education Medical Media Patients 89

PM360

OCTOBER 13, 2023

“They are effective but too expensive for the majority of patients, even with insurance coverage,” said one primary care physician (PCP). And while they’re excited about the drugs’ results and limited side effects now, many also noted concerns about the lack of safety data and long-term risks.

Healthcare 59

Healthcare Healthcare Doctors Pharma 59

PM360

JUNE 11, 2022

Then, the MRL team and the influencer must align on where there is flexibility within messaging while still abiding to brand safety guidelines, as you don’t want to lose the authenticity that the influencer brings. Their authenticity and credibility is their superpower—don’t diminish that by being overly prescriptive. Rishi Kadiwar.

Patients 59

Patients Pharma Education Media 59